Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-24T21:20:19.320Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevention of Nosocomial Infections in Marrow Transplant Patients: A Prospective Randomized Comparison of Systemic Antibiotics Versus Granulocyte Transfusions

Published online by Cambridge University Press:  02 January 2015

Finn B. Petersen ,
C.D. Buckner ,
Reginald A. Clift ,
Nira Nelson ,
George W. Counts ,
Joel D. Meyers  and
E.D. Thomas
Finn B. Petersen*
Affiliation:
Fred Hutchinson Cancer Research Center, the Swedish Hospital Medical Centerand the University of Washington School of Medicine, Seattle, Washington
C.D. Buckner
Affiliation:
Fred Hutchinson Cancer Research Center, the Swedish Hospital Medical Centerand the University of Washington School of Medicine, Seattle, Washington
Reginald A. Clift
Affiliation:
Fred Hutchinson Cancer Research Center, the Swedish Hospital Medical Centerand the University of Washington School of Medicine, Seattle, Washington
Nira Nelson
Affiliation:
Fred Hutchinson Cancer Research Center, the Swedish Hospital Medical Centerand the University of Washington School of Medicine, Seattle, Washington
George W. Counts
Affiliation:
Fred Hutchinson Cancer Research Center, the Swedish Hospital Medical Centerand the University of Washington School of Medicine, Seattle, Washington
Joel D. Meyers
Affiliation:
Fred Hutchinson Cancer Research Center, the Swedish Hospital Medical Centerand the University of Washington School of Medicine, Seattle, Washington
E.D. Thomas
Affiliation:
Fred Hutchinson Cancer Research Center, the Swedish Hospital Medical Centerand the University of Washington School of Medicine, Seattle, Washington
*
Fred Hutchinson Cancer Research Center, 1124 Columbia Street, Seattle, WA 98104.
Get access Rights & Permissions [Opens in a new window]

Abstract

One hundred twelve patients with hematologic malignancies underwent marrow transplantation from HLA-matched sibling donors and were randomized to receive either prophylactic granulocyte transfusions (PG, 67 patients) or prophylactic systemic antibiotics (PSA, 45 patients) as prophylaxis against nosocomial infections. Patients were treated in conventional hospital rooms and studied until day 100 post-transplant. For the entire study period, 26 patients (39%) in the PG group developed septicemia compared to 15 patients (33%) in the PSA group. Twenty-eight patients (42%) in the PG group developed local major infections compared to 19 patients (42%) in the PSA group. Ten patients (15%) in the PG group developed viral interstitial pneumonitis compared to 6 patients (13%) in the PSA group. None of these differences were statistically significant. There was no difference in the incidence of bacterial or fungal infections or viral interstitial pneumonitis between the two groups during the granulocytopenic or post-engraftment period. There was no difference in the incidence and severity of graft-versus-host-disease (GVHD). Inability to carry out the prophylaxis was frequent in the PG group, with complications necessitating discontinuance of transfusion in 24% of the recipients and 13% of the donors. The use of PG as an infection prophylaxis modality in marrow transplantation is not supported by this study, as it is difficult to carry out and because PG did not show any advantage over the use of PSA in preventing nosocomial infections.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 7 , Issue 12 , December 1986 , pp. 586 - 592
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Clift, RA, Buckner, CD, Fefer, A, et al: Infectious complications of marrow transplantation. Transplant Proc 1974; 6:389–393.Google ScholarPubMed
2. Watson, JG: Problems of infection after bone marrow transplantation. J Clin Pathol 1983; 36:683–692.CrossRefGoogle ScholarPubMed
3. Winston, DJ, Ho, WG, Champlin, RE, et al: Infectious complications of bone marrow transplantation. Exp Hematol 1984; 12:205–215.Google ScholarPubMed
4. Bacigalupo, A, Van Lint, MT, Frassoni, F, et al: Infections in a bone marrow transplant unit: Analysis of 57 patients. Haematologica 1984; 69:41–52.Google Scholar
5. Clift, RA, Sanders, JE, Thomas, ED, et al: Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplants. N Engl J Med 1978; 298:1052–1057.Google Scholar
6. Winston, DJ, Ho, WG, Young, LS, et al: Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med 1980; 68:893–897.Google Scholar
7. Buckner, CD, Clift, RA, Sanders, JE, et al: Prophylactic granulocyte transfusions, in Vogler, WR (ed): Cytapheresis and Plasma Exchange: Clinkal Indications. New York, Alan R Liss lnc, 1982, pp 93–100.Google Scholar
8. Buckner, CD, Clift, RA, Thomas, ED, et al: Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: Effects of prophylactic measures. Infection 1983; 11:243–250.CrossRefGoogle ScholarPubMed
9. Bodey, GP, Gehan, EA, Freireich, EJ, et al: Protected environment—Prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci 1971; 262:138–151.Google Scholar
10. Levine, AS, Siegel, SE, Schreiber, AD, et al: Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med 1973; 288:477–483.Google Scholar
11. Bodey, GP: Current status of prophylaxis of infection with protected environments. Am J Med 1984; 76:678–684.Google Scholar
12. Hersman, J, Meyers, JD, Thomas, ED, et al: The effect of granulocyte transfusions upon the incidence of cytomegalovirus infections after allogeneic marrow transplantation. Ann Intern Med 1982; 96:149–152.Google Scholar
13. Thomas, ED: The use and potential of bone marrow allograft and whole-body irradiation in the treatment of leukemia. Cancer 1982; 50:1449–1454.3.0.CO;2-P>CrossRefGoogle ScholarPubMed
14. Deeg, HJ, Storb, R, Thomas, ED, et al: Cyclosporine as prophylaxis for graftversus-host disease: A randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 1985; 65:1325–1334.CrossRefGoogle Scholar
15. Storb, R, Deeg, HJ, Thomas, ED, et al: Marrow transplantation for chronic myelocytic leukemia: A controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. Blood 1985; 66:698–702.Google Scholar
16. Thomas, ED, Storb, R, Clift, RA, et al: Bone-marrow transplantation. N Engl J Med 1975; 292:832-843, 895–902.Google Scholar
17. Storb, R, Thomas, ED: Allogeneic bone-marrow transplantation. Immunol Rev 1983; 71:77–102.CrossRefGoogle ScholarPubMed
18. Petersen, FB, Clift, RA, Hickman, RO, et al: Hickman catheter complications in marrow transplant recipients. JPEN 1986; 10:58–62.Google Scholar
19. Winston, DJ, Ho, WG, Howell, CL, et al: Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med 1980; 93:671–675.Google Scholar
20. Meyers, JD, Flournoy, N, Wade, JC, et al: Biology of interstitial pneumonia after marrow transplantation, in Gale, RP (ed): Recent Advances in Bone Marrow Transplantation. New York, Alan R Liss lnc, 1983, pp 405–423.Google Scholar
21. Kaplan, EL, Meier, P: Nonparametric estimation from incomplete observations. J Am Statistical Assoc 1958; 53:457–481.Google Scholar
22. Peto, R, Peto, J: Asymptotically efficient rank invariant test procedures (with discussions). J Royal Statistical Society A 1972; 135:185–206.CrossRefGoogle Scholar
23. Petersen, FB, Buckner, CD, Clift, RA, et al: Laminar air flow isolation and decontamination: A prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients. Infection, in press.Google Scholar
24. Ross, AH, Griffith, CD, Anderson, JR, et al: Thromboembolic complications with silicone elastomer subclavian catheters, JPEN 1982; 6:61–63.Google Scholar
25. Smith, VC, Hallett, JW Jr: Subclavian vein thrombosis during prolonged catheterization for parenteral nutrition: Early management and long-term follow-up. South Med J 1983; 76:603–606.CrossRefGoogle ScholarPubMed
26. Wright, DG, Robichaud, KJ, Pizzo, PA, et al: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981; 304:1185–1189.Google Scholar